Yok
Objective: Medication-related osteonecrosis of the jaw (MRONJ) is a serious condition affecting the quality of life of patients taking antiresorptive and anti-angiogenic drugs. The main purpose of this study was to evaluate dentists’ awareness of MRONJ.
Methods: A questionnaire was administered to dentists. The questionnaire contained 20 questions on the demographic data of the participants and their awareness of MRONJ and the complications of antiresorptive or anti-angiogenic drugs. The responses were analyzed using Pearson’s chi-square test and Fisher’s exact test.
Results: In total, 141 dentists participated in the survey. Of these, 42.6% did not know about MRONJ. There was a statistically significant difference between specialist dentists and general dentists on the questions about the complications, effects, and usage of antiresorptive and anti-angiogenic drugs on necrosis formation (p<0.05). Dentists with less experience (seven years’<) were more knowledgeable about MRONJ (86.7%); compared to those with more than seven years’ clinical experience.
Conclusions: This study showed that the knowledge level of dentists regarding the side effects of antiresorptive and anti-angiogenic medications is weak. Overall, MRONJ awareness among general dentists was poor.
Antiresorptive antiangiogenic medications medication-related osteonecrosis of the jaw
Birincil Dil | İngilizce |
---|---|
Konular | Sağlık Kurumları Yönetimi |
Bölüm | Articles |
Yazarlar | |
Yayımlanma Tarihi | 31 Mart 2021 |
Gönderilme Tarihi | 9 Mart 2020 |
Yayımlandığı Sayı | Yıl 2021 Cilt: 11 Sayı: 1 |